Literature DB >> 17581191

Animal models of asthma.

G R Zosky1, P D Sly.   

Abstract

Animal models of asthma are a tool that allows studies to be conducted in the setting of an intact immune and respiratory system. These models have highlighted the importance of T-helper type 2 driven allergic responses in the progression of asthma and have been useful in the identification of potential drug targets for interventions involving allergic pathways. However, a number of drugs that have been shown to have some efficacy in animal models of asthma have shown little clinical benefit in human asthmatics. This may be due to a number of factors including the species of animal chosen and the methods used to induce an asthmatic phenotype in animals that do not normally develop a disease that could be characterized as asthma. The range of animal models available is vast, with the most popular models being rodents (inbred mice and rats) and guinea-pigs, which have the benefit of being easy to handle and being relatively cost effective compared with other models that are available. The recent advances in transgenic technology and the development of species-specific probes, particularly in mice, have allowed detailed mechanistic studies to be conducted. Despite these advances in technology, there are a number of issues with current animal models of asthma that must be recognized including the disparity in immunology and anatomy between these species and humans, the requirement for adjuvant during senitization in most models, the acute nature of the allergic response that is induced and the use of adult animals as the primary disease model. Some larger animal models using sheep and dogs have been developed that may address some of these issues but they also have different biology from humans in many ways and are extremely costly, with very few probes available for characterizing allergic responses in the airway in these species. As research in this area continues to expand, the relative merits and limitations of each model must be defined and understood in order to evaluate the information that is obtained from these models and to extrapolate these findings to humans so that effective drug therapies can be developed. Despite these issues, animal models have been, and will continue to be, vital in understanding the mechanisms that are involved in the development and progression of asthma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581191     DOI: 10.1111/j.1365-2222.2007.02740.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  92 in total

1.  Assessing pulmonary pathology by detailed examination of respiratory function.

Authors:  Louis J Vaickus; Jacqueline Bouchard; Jiyoun Kim; Sudha Natarajan; Daniel G Remick
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 2.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

3.  The importance of reporting house dust mite endotoxin abundance: impact on the lung transcriptome.

Authors:  Christopher D Pascoe; Aruni Jha; Sujata Basu; Thomas Mahood; Amy Lee; Sam Hinshaw; Reza Falsafi; Robert E W Hancock; Neeloffer Mookherjee; Andrew J Halayko
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-22       Impact factor: 5.464

4.  Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.

Authors:  Cesar E Ochoa; Seyedeh Golsar Mirabolfathinejad; Venado Ana Ruiz; Scott E Evans; Mihai Gagea; Christopher M Evans; Burton F Dickey; Seyed Javad Moghaddam
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-22

5.  Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function.

Authors:  Laura E Crotty Alexander; Kathryn Akong-Moore; Stephanie Feldstein; Per Johansson; Anh Nguyen; Elisa K McEachern; Shari Nicatia; Andrew S Cowburn; Joshua Olson; Jae Youn Cho; Hart Isaacs; Randall S Johnson; David H Broide; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2012-12-19       Impact factor: 4.599

6.  Airway and lung pathology due to mucosal surface dehydration in {beta}-epithelial Na+ channel-overexpressing mice: role of TNF-{alpha} and IL-4R{alpha} signaling, influence of neonatal development, and limited efficacy of glucocorticoid treatment.

Authors:  Alessandra Livraghi; Barbara R Grubb; Elizabeth J Hudson; Kristen J Wilkinson; John K Sheehan; Marcus A Mall; Wanda K O'Neal; Richard C Boucher; Scott H Randell
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

7.  Identification of novel chromosomal regions associated with airway hyperresponsiveness in recombinant congenic strains of mice.

Authors:  Pierre Camateros; Rafael Marino; Anny Fortin; James G Martin; Emil Skamene; Rob Sladek; Danuta Radzioch
Journal:  Mamm Genome       Date:  2009-12-15       Impact factor: 2.957

Review 8.  Key mediators in the immunopathogenesis of allergic asthma.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Int Immunopharmacol       Date:  2014-06-13       Impact factor: 4.932

Review 9.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

10.  Human airway musculature on a chip: an in vitro model of allergic asthmatic bronchoconstriction and bronchodilation.

Authors:  Alexander Peyton Nesmith; Ashutosh Agarwal; Megan Laura McCain; Kevin Kit Parker
Journal:  Lab Chip       Date:  2014-10-21       Impact factor: 6.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.